New Market Study Published: Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2012
Global Markets Direct's, 'Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Pancreatic Ductal Adenocarcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pancreatic Ductal Adenocarcinoma. Pancreatic Ductal Adenocarcinoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release